← Leaderboards
Salim Shah
Hingez Therapeutics, Inc.
$982,123
Attributed
$1,964,245
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–19$2M$1.5M$1M$500K$0
'18
'19
Funding mix
By agency
NIH$1,964,245 · 1
By mechanism
R44$1,964,245 · 1
Top collaborators
- Peter U Feig3 shared
Most similar at Hingez Therapeutics, Inc.
Same institution · by research overlap
- Peter U Feig$1,112,752
- Jerome Baudry$130,630
Others in their field
Other Emerging Leaders on “Accounting”
- Martha Hering · Westat, Inc.$57,098,843
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Pamela Winer Goldberg · Medical Device Innovation Consortium$28,780,000
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
Research focus
AccountingAbcb1 GeneAffinityAnalogAnimal EfficacyAreaAtherosclerosisAtherosclerosis RiskBackBaseBindingBloodCaco-2 CellsCardiovascular DiseasesCatalytic DomainCause Of DeathCell MembraneCell SurfaceCellular AssayCessation Of LifeCholesterolCholesterol ControlCholesterol HomeostasisComputer Simulation